Study to Describe Treatment Patterns and Outcomes in EGFRm NSCLC Patients in Belgium

Clinical trial NCT03761901 · COMPLETED

Trial details

NCT number: NCT03761901
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Carcinoma, Non-Small-Cell Lung

Start date: 2018-09-21
Primary completion: 2019-06-19
Enrollment: 141

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.